| Aug 20 |
Dr. Reddy’s Laboratories, Aurigene Pharmaceutical Services, and Kainomyx Announce Potential Partnership for Joint Development of Affordable Anti-Malarial Drug
|
| Aug 13 |
Dr. Reddy's Laboratories: Economic Factors Square Off To Reiterate Buy
|
| Jul 29 |
Dr. Reddy's gets positive EMA opinion for rituximab biosimilar
|
| Jul 29 |
Dr. Reddy’s Receives Positive CHMP Opinion From European Medicines Agency for Its Proposed Rituximab Biosimilar
|
| Jul 29 |
Dr. Reddy's (RDY) Q1 Earnings Miss Estimates, Revenues Beat
|
| Jul 29 |
Dr. Reddy's goes ex dividend tomorrow
|
| Jul 29 |
Dr. Reddy's GAAP EPS of $1.00, revenue of $921M beats by $17.51M
|
| Jul 27 |
Dr. Reddy’s Q1FY25 Financial Results
|
| Jun 26 |
Dr. Reddy’s to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare Business
|
| Jun 26 |
Haleon to sell overseas nicotine therapy business to Dr. Reddy’s
|
